Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 1501 AL 1515

The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer's Disease-related Pathogenesis

Jeon SG, Yoo A, Chun DW, Hong SB, Chung H, Kim JI, Moon M.

Aging Dis. 2020 May 9;11(3):705-724. doi: 10.14336/AD.2019.0718. eCollection 2020 May.

Parkinsonism Secondary to Hydrocephalus Caused by Neurocysticercosis

Oliveira SCS, Monteiro DAM, Silva GF, Santos LTR, Ribeiro EML.

Cureus. 2020 Apr 29;12(4):e7887. doi: 10.7759/cureus.7887.

The human olfactory system in two proteinopathies: Alzheimer's and Parkinson's diseases

Ubeda-Bañon I, Saiz-Sanchez D, Flores-Cuadrado A, Rioja-Corroto E, Gonzalez-Rodriguez M, Villar-Conde S, Astillero-Lopez V, Cabello-de la Rosa JP, Gallardo-Alcañiz MJ, Vaamonde-Gamo J, Relea-Calatayud F, Gonzalez-Lopez L, Mohedano-Moriano A, Rabano A, Martinez-Marcos A.

Transl Neurodegener. 2020 Jun 3;9(1):22. doi: 10.1186/s40035-020-00200-7.

The effect of STN DBS on modulating brain oscillations: consequences for motor and cognitive behavior

David FJ, Munoz MJ, Corcos DM.

Exp Brain Res. 2020 Aug;238(7-8):1659-1676. doi: 10.1007/s00221-020-05834-7. Epub 2020 Jun 3.

Effects of Environmental Enrichment on Neurotrophins in an MPTP-Induced Parkinson's Disease Animal Model: A Randomized Trial

Cho H, Kang K.

Biol Res Nurs. 2020 Oct;22(4):506-513. doi: 10.1177/1099800420931183. Epub 2020 Jun 4.

Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson's disease management

Sola P, Krishnamurthy P, Chintamaneni PK, Pindiprolu SKSS, Kumari M.

Expert Opin Drug Deliv. 2020 Aug;17(8):1119-1132. doi: 10.1080/17425247.2020.1779218. Epub 2020 Jun 22.

Loss of ventricular preexcitation during noninvasive testing does not exclude high-risk accessory pathways: A multicenter study of WPW in children

Escudero CA, Ceresnak SR, Collins KK, Pass RH, Aziz PF, Blaufox AD, Ortega MC, Cannon BC, Cohen MI, Dechert BE, Dubin AM, Motonaga KS, Epstein MR, Erickson CC, Fishberger SB, Gates GJ, Capone CA, Nappo L, Kertesz NJ, Kim JJ, Valdes SO, Kubuš P, Law IH, Maldonado J, Moore JP, Perry JC, Sanatani S, Seslar SP, Shetty I, Zimmerman FJ, Skinner JR, Marcondes L, Stephenson EA, Asakai H, Tanel RE, Uzun O, Etheridge SP, Janson CM.

Heart Rhythm. 2020 Oct;17(10):1729-1737. doi: 10.1016/j.hrthm.2020.05.035. Epub 2020 Jun 1.

Optical Coherence Tomography Angiography in Neurodegenerative Disorders

Pellegrini M, Vagge A, Ferro Desideri LF, Bernabei F, Triolo G, Mastropasqua R, Del Noce CD, Borrelli E, Sacconi R, Iovino C, Di Zazzo AD, Forlini M, Giannaccare G.

J Clin Med. 2020 Jun 2;9(6):1706. doi: 10.3390/jcm9061706.

Treatment of Acute Delirium in a Patient with Parkinson's Disease by Transfer to the Intensive Care Unit and Administration of Dexmedetomidine

Lombardo M, DiPiazza A, Rippey K, Lubarr N, Clar E, Azmi H.

J Mov Disord. 2020 May;13(2):159-162. doi: 10.14802/jmd.20005. Epub 2020 May 29.

The Evolution-Driven Signature of Parkinson's Disease

Diederich NJ, Uchihara T, Grillner S, Goetz CG.

Trends Neurosci. 2020 Jul;43(7):475-492. doi: 10.1016/j.tins.2020.05.001. Epub 2020 Jun 1.

Role of mtDNA disturbances in the pathogenesis of Alzheimer's and Parkinson's disease

Antonyová V, Kejík Z, Brogyányi T, Kaplánek R, Pajková M, Talianová V, Hromádka R, Masařík M, Sýkora D, Mikšátková L, Martásek P, Jakubek M.

DNA Repair (Amst). 2020 Jul-Aug;91-92:102871. doi: 10.1016/j.dnarep.2020.102871. Epub 2020 May 21.

Molecular Regulation in Dopaminergic Neuron Development. Cues to Unveil Molecular Pathogenesis and Pharmacological Targets of Neurodegeneration

Volpicelli F, Perrone-Capano C, Bellenchi GC, Colucci-D'Amato L, di Porzio U.

Int J Mol Sci. 2020 Jun 3;21(11):3995. doi: 10.3390/ijms21113995.

Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders

Machhi J, Kevadiya BD, Muhammad IK, Herskovitz J, Olson KE, Mosley RL, Gendelman HE.

Mol Neurodegener. 2020 Jun 5;15(1):32. doi: 10.1186/s13024-020-00375-7.

Mechanisms of neurodegeneration in Parkinson's disease: keep neurons in the PINK1

Brunelli F, Valente EM, Arena G.

Mech Ageing Dev. 2020 Jul;189:111277. doi: 10.1016/j.mad.2020.111277. Epub 2020 Jun 3.

Opioid system influences gut-brain axis: Dysbiosis and related alterations

Rueda-Ruzafa L, Cruz F, Cardona D, Hone AJ, Molina-Torres G, Sánchez-Labraca N, Roman P.

Pharmacol Res. 2020 Sep;159:104928. doi: 10.1016/j.phrs.2020.104928. Epub 2020 Jun 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias